News Summary: Bristol-Myers swings to 3Q loss

Associated Press Published: October 24, 2012

ROUGH QUARTER: Bristol-Myers Squibb Co. swings to a $711 million loss on a $1.8 billion charge for failed research and generic competition with decimated sales. It misses analysts' expectations and slashes its 2012 profit forecast.

THE NUMBERS: The loss equals 43 cents per share. Excluding charges Bristol made $969 million, or 56 cents per share. Generic competition to drugs including blood thinner Plavix, which had been the world's second-best-selling drug, cuts revenue 30 percent to $3.74 billion.

THE REACTION: One analyst says Bristol won't see much growth before 2020, and shares slide.


Trending Now


  1. 1
    Former OU coach Sunny Golloway goes off at Auburn
  2. 2
    Chelsea Clinton Is Pregnant
  3. 3
    Tulsa World: Missouri’s Frank Haith positioned to become TU’s basketball coach
  4. 4
    Oklahoma football: Peyton Manning stops by Sooners film session
  5. 5
    VIDEO: A look at the Air Jordan XX9 in Thunder colors
+ show more